nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethizole—Sulfaphenazole—CYP2B6—malignant glioma	0.19	0.319	CrCbGaD
Sulfamethizole—Dapsone—CYP2C18—malignant glioma	0.17	0.285	CrCbGaD
Sulfamethizole—Sulfamethoxazole—PTGS1—malignant glioma	0.106	0.178	CrCbGaD
Sulfamethizole—Dapsone—PTGS1—malignant glioma	0.0828	0.139	CrCbGaD
Sulfamethizole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0531	0.131	CbGpPWpGaD
Sulfamethizole—Dapsone—PTGS2—malignant glioma	0.0473	0.0795	CrCbGaD
Sulfamethizole—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.0224	0.0554	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.0164	0.0404	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.0156	0.0387	CbGpPWpGaD
Sulfamethizole—ALB—Binding and Uptake of Ligands by Scavenger Receptors—FTH1—malignant glioma	0.0144	0.0357	CbGpPWpGaD
Sulfamethizole—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.0139	0.0343	CbGpPWpGaD
Sulfamethizole—ALB—Transport of vitamins, nucleosides, and related molecules—APOD—malignant glioma	0.013	0.0322	CbGpPWpGaD
Sulfamethizole—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.012	0.0298	CbGpPWpGaD
Sulfamethizole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00954	0.0236	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00909	0.0225	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.00783	0.0194	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—CSF1—malignant glioma	0.00597	0.0148	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.00593	0.0147	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00577	0.0143	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00569	0.0141	CbGpPWpGaD
Sulfamethizole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.005	0.0124	CbGpPWpGaD
Sulfamethizole—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00494	0.0122	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00468	0.0116	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00439	0.0108	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00405	0.01	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—SOD1—malignant glioma	0.004	0.00988	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—PTGS1—malignant glioma	0.00341	0.00843	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—SOD1—malignant glioma	0.00325	0.00804	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.00313	0.00774	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—CAT—malignant glioma	0.00309	0.00764	CbGpPWpGaD
Sulfamethizole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00307	0.0076	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—KNG1—malignant glioma	0.003	0.00742	CbGpPWpGaD
Sulfamethizole—ALB—Lipid and lipoprotein metabolism—CAV1—malignant glioma	0.00297	0.00734	CbGpPWpGaD
Sulfamethizole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00291	0.00719	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00286	0.00707	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—APOD—malignant glioma	0.0028	0.00692	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—SOD1—malignant glioma	0.00279	0.00689	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—DOCK6—malignant glioma	0.00279	0.00689	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—F2—malignant glioma	0.00278	0.00688	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.00266	0.00657	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—SOD1—malignant glioma	0.00258	0.00639	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00248	0.00614	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—CAT—malignant glioma	0.00245	0.00607	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00245	0.00606	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—F2—malignant glioma	0.00226	0.0056	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00215	0.00532	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—PDGFB—malignant glioma	0.00215	0.00532	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.00212	0.00525	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IFNG—malignant glioma	0.00211	0.00521	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.00205	0.00507	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—FN1—malignant glioma	0.00194	0.0048	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—IL1B—malignant glioma	0.00188	0.00465	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.00185	0.00457	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—EGF—malignant glioma	0.00184	0.00454	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00183	0.00452	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—F2—malignant glioma	0.0018	0.00444	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.00175	0.00432	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.00174	0.00431	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IFNG—malignant glioma	0.00172	0.00424	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ATP1B2—malignant glioma	0.00169	0.00418	CbGpPWpGaD
Sulfamethizole—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.00168	0.00416	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00167	0.00414	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00163	0.00404	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL1B—malignant glioma	0.00153	0.00378	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—IL2—malignant glioma	0.00152	0.00377	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—RTEL1—malignant glioma	0.00149	0.00369	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00146	0.00361	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	0.00142	0.00352	CbGpPWpGaD
Sulfamethizole—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	0.00136	0.00337	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	0.00136	0.00337	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.00133	0.00329	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00132	0.00325	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.00131	0.00323	CbGpPWpGaD
Sulfamethizole—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00125	0.0031	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—ANGPT2—malignant glioma	0.00125	0.00308	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.00124	0.00306	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—RTEL1—malignant glioma	0.00122	0.00302	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.00122	0.003	CbGpPWpGaD
Sulfamethizole—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.00121	0.00299	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.00119	0.00294	CbGpPWpGaD
Sulfamethizole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00114	0.00283	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.00114	0.00281	CbGpPWpGaD
Sulfamethizole—ALB—Platelet degranulation—VEGFA—malignant glioma	0.00111	0.00275	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TNF—malignant glioma	0.00111	0.00274	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—HIST1H3B—malignant glioma	0.00108	0.00267	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—MYB—malignant glioma	0.00107	0.00264	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00107	0.00264	CbGpPWpGaD
Sulfamethizole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.00106	0.00262	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00103	0.00255	CbGpPWpGaD
Sulfamethizole—ALB—Folate Metabolism—TP53—malignant glioma	0.000979	0.00242	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000954	0.00236	CbGpPWpGaD
Sulfamethizole—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000882	0.00218	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000872	0.00216	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000861	0.00213	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000861	0.00213	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—COX8A—malignant glioma	0.000857	0.00212	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000844	0.00209	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—H3F3A—malignant glioma	0.000833	0.00206	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000824	0.00204	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000814	0.00201	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000766	0.00189	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000754	0.00186	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—ASMT—malignant glioma	0.000728	0.0018	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000728	0.0018	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000724	0.00179	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000712	0.00176	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—COX8A—malignant glioma	0.000701	0.00173	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—KNG1—malignant glioma	0.000686	0.0017	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—BCAN—malignant glioma	0.000685	0.00169	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IFNA2—malignant glioma	0.000672	0.00166	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000669	0.00165	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000646	0.0016	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—SOD1—malignant glioma	0.000637	0.00158	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000636	0.00157	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000631	0.00156	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000627	0.00155	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—ASMT—malignant glioma	0.000596	0.00147	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PTK2—malignant glioma	0.000585	0.00145	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000583	0.00144	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.00058	0.00143	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—BCAN—malignant glioma	0.000561	0.00139	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—IDH2—malignant glioma	0.000552	0.00136	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00052	0.00129	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP2B6—malignant glioma	0.000519	0.00128	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.000493	0.00122	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PDGFB—malignant glioma	0.000492	0.00122	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—IDH1—malignant glioma	0.000475	0.00117	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—CAV1—malignant glioma	0.000466	0.00115	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—SPHK1—malignant glioma	0.000459	0.00114	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—IDH2—malignant glioma	0.000452	0.00112	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CYP2C18—malignant glioma	0.00045	0.00111	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—F2—malignant glioma	0.000444	0.0011	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—FN1—malignant glioma	0.000444	0.0011	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000426	0.00105	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000425	0.00105	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CG—malignant glioma	0.000425	0.00105	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000424	0.00105	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—EGF—malignant glioma	0.00042	0.00104	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PTPN11—malignant glioma	0.000417	0.00103	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—IDH1—malignant glioma	0.000389	0.000961	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—AKT2—malignant glioma	0.000388	0.00096	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000386	0.000956	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000385	0.000951	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000376	0.00093	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CD—malignant glioma	0.000373	0.000923	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000373	0.000922	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000368	0.000911	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTT1—malignant glioma	0.000364	0.0009	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000347	0.000859	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PTGS1—malignant glioma	0.000341	0.000843	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00034	0.00084	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—RAF1—malignant glioma	0.000333	0.000824	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CB—malignant glioma	0.000325	0.000804	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—BCHE—malignant glioma	0.000317	0.000784	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000316	0.000782	CbGpPWpGaD
Sulfamethizole—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000314	0.000777	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—SLC5A5—malignant glioma	0.000313	0.000774	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000305	0.000755	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—IL2—malignant glioma	0.000299	0.000739	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTT1—malignant glioma	0.000298	0.000736	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000296	0.000732	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000293	0.000726	CbGpPWpGaD
Sulfamethizole—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000288	0.000713	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000279	0.00069	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000278	0.000688	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—BCHE—malignant glioma	0.000259	0.000642	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000256	0.000634	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000256	0.000633	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—VEGFA—malignant glioma	0.000254	0.000628	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—GSTP1—malignant glioma	0.000252	0.000624	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CAT—malignant glioma	0.000245	0.000607	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000242	0.000599	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00024	0.000594	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—NCOR1—malignant glioma	0.000232	0.000573	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—KRAS—malignant glioma	0.000216	0.000534	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000209	0.000518	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—GSTP1—malignant glioma	0.000206	0.00051	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CAT—malignant glioma	0.000201	0.000497	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—PIK3CA—malignant glioma	0.000198	0.00049	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—TP53—malignant glioma	0.000192	0.000474	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—NCOR1—malignant glioma	0.00019	0.000469	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—CAV1—malignant glioma	0.000189	0.000467	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000181	0.000446	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CG—malignant glioma	0.000172	0.000426	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PPARG—malignant glioma	0.000166	0.000411	CbGpPWpGaD
Sulfamethizole—ALB—Hemostasis—AKT1—malignant glioma	0.000162	0.000401	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—CAV1—malignant glioma	0.000155	0.000382	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CD—malignant glioma	0.000151	0.000374	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000148	0.000365	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CG—malignant glioma	0.000141	0.000348	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PPARG—malignant glioma	0.000136	0.000336	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CB—malignant glioma	0.000132	0.000326	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PTGS2—malignant glioma	0.000131	0.000323	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CD—malignant glioma	0.000124	0.000306	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PTEN—malignant glioma	0.000114	0.000282	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CB—malignant glioma	0.000108	0.000267	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PTGS2—malignant glioma	0.000107	0.000264	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PTEN—malignant glioma	9.33e-05	0.000231	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—PIK3CA—malignant glioma	8.04e-05	0.000199	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.58e-05	0.000163	CbGpPWpGaD
Sulfamethizole—ALB—Metabolism—AKT1—malignant glioma	6.57e-05	0.000162	CbGpPWpGaD
Sulfamethizole—CYP2C9—Metabolism—AKT1—malignant glioma	5.38e-05	0.000133	CbGpPWpGaD
